Alone, the analytical chemistry and embryonic morphology assays detected adverse outcomes suggestive of PAH bioactivity, but the added dimension of transcriptomics uncovered not only PAH transcriptional signatures, but also perturbation of the visual and musculature systems uncharacteristic of canonical AHR ligand toxicity. This evidence concerns the gene AHR and pulmonary arterial hypertension.